Accident & Pain Relief of St. Louis Logo

Downtown St. Louis, MO natural fibromyalgia treatmentIf you are struggling with fibromyalgia, you are not alone, as Dr. Holland sees many people with this particular condition in our Downtown St. Louis, MO chiropractic clinic. Actually, the Centers for Disease Control and Prevention (CDC) estimates that roughly two percent of all adults in the United States have fibromyalgia. Fortunately, chiropractic care is one treatment option that can provide positive results.

Research Shows Chiropractic Eases Fibromyalgia

In a study released in mid-2015, 215 adults with fibromyalgia were evaluated based on factors ranging from pain to quality of sleep to the levels of depression and anxiety they felt. Then they were divided into two groups with one group receiving a multi-modal therapy plan for three months and the second group receiving the same program plus chiropractic adjustments (specifically, to the upper neck tissues) for the same length of time.

The subjects who received chiropractic adjustments in conjunction with the multi-modal treatment approach reported greater results in all areas (pain, sleep, depression, and anxiety) at 12 weeks post-treatment when compared to the study patients who received multi-modal treatment without chiropractic. Additionally, those positive results were long-lasting as the people reported continued improvement one full year later.

Fibromyalgia can significantly reduce your quality of life, both mentally and physically. If you're dealing with fibromyalgia, we might be able to help.

You don't have to suffer! To see what Dr. Holland can do for your fibromyalgia pain, call our Downtown St. Louis, MO chiropractic office today.

Research

  • Fibromyalgia. Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/arthritis/basics/fibromyalgia.htm on November 2, 2015.
  • Moustafa I & Diab A. (2015, July). The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial. Rheumatology International;35(7):1163-74.